Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $116,600 | 79 | 71.8% |
| Food and Beverage | $27,531 | 1,402 | 17.0% |
| Travel and Lodging | $17,532 | 41 | 10.8% |
| Consulting Fee | $555.00 | 3 | 0.3% |
| Education | $158.79 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $98,938 | 302 | $0 (2024) |
| Lilly USA, LLC | $39,088 | 116 | $0 (2023) |
| Amgen Inc. | $9,536 | 233 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,208 | 175 | $0 (2024) |
| PFIZER INC. | $1,489 | 130 | $0 (2024) |
| Genentech USA, Inc. | $1,242 | 100 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $797.58 | 38 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $783.53 | 42 | $0 (2019) |
| Celgene Corporation | $755.54 | 47 | $0 (2019) |
| Janssen Biotech, Inc. | $734.03 | 48 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,361 | 107 | ABBVIE INC. ($17,875) |
| 2023 | $14,237 | 76 | AbbVie Inc. ($7,351) |
| 2022 | $29,290 | 119 | ABBVIE INC. ($22,266) |
| 2021 | $17,001 | 78 | Lilly USA, LLC ($14,956) |
| 2020 | $28,137 | 84 | Lilly USA, LLC ($16,069) |
| 2019 | $28,516 | 398 | AbbVie, Inc. ($22,932) |
| 2018 | $15,969 | 364 | AbbVie, Inc. ($10,460) |
| 2017 | $9,865 | 308 | AbbVie, Inc. ($5,522) |
All Payment Transactions
1,534 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $66.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $122.62 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $560.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $104.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,709 | 35,509 | $2.0M | $660,989 |
| 2022 | 24 | 1,717 | 40,522 | $2.1M | $648,235 |
| 2021 | 22 | 1,649 | 18,344 | $1.4M | $433,628 |
| 2020 | 18 | 1,362 | 16,189 | $1.0M | $351,729 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 244 | 23,820 | $1.2M | $439,030 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 436 | 827 | $291,931 | $79,873 | 27.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 11 | 9,240 | $277,200 | $73,306 | 26.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 263 | 263 | $62,496 | $11,260 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $31,710 | $9,308 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 57 | $27,987 | $8,639 | 30.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $23,880 | $7,232 | 30.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 261 | 597 | $41,193 | $6,777 | 16.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 34 | 57 | $15,732 | $4,913 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 58 | $14,442 | $4,250 | 29.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 11 | 18 | $14,421 | $3,465 | 24.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 65 | $12,935 | $3,445 | 26.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $6,560 | $2,877 | 43.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 36 | $7,740 | $2,422 | 31.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $2,829 | $1,349 | 47.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 52 | 138 | $2,110 | $822.39 | 39.0% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 11 | 19 | $2,812 | $794.44 | 28.3% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 21 | 21 | $2,100 | $741.93 | 35.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 22 | 34 | $884.00 | $318.10 | 36.0% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 19 | 30 | $450.00 | $149.10 | 33.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 13 | 38 | $59.28 | $17.95 | 30.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 207 | 19,860 | $993,000 | $340,781 | 34.3% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 12 | 17,854 | $452,379 | $134,157 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 423 | 970 | $342,410 | $95,302 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 82 | $40,262 | $11,714 | 29.1% |
About Dr. Stuart Segal, M.D
Dr. Stuart Segal, M.D is a Rheumatology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508879354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Segal, M.D has received a total of $162,377 in payments from pharmaceutical and medical device companies, with $19,361 received in 2024. These payments were reported across 1,534 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($116,600).
As a Medicare-enrolled provider, Segal has provided services to 6,437 Medicare beneficiaries, totaling 110,564 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Santa Barbara, CA
- Active Since 08/14/2006
- Last Updated 11/04/2010
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1508879354
Products in Payments
- TALTZ (Drug) $38,156
- SKYRIZI (Biological) $25,675
- RINVOQ (Biological) $22,650
- Humira (Biological) $13,665
- Rinvoq (Biological) $10,739
- RINVOQ (Drug) $8,185
- Otezla (Drug) $5,493
- Enbrel (Biological) $2,521
- COSENTYX (Biological) $2,361
- XELJANZ (Drug) $1,157
- ACTHAR (Biological) $1,053
- Rituxan (Biological) $1,045
- BENLYSTA (Biological) $649.20
- Cimzia (Drug) $648.27
- Prolia (Biological) $631.03
- COSENTYX (Drug) $606.50
- ORENCIA (Biological) $567.96
- KEVZARA (Drug) $563.66
- SIMPONI ARIA (Biological) $557.67
- EVENITY (Biological) $516.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Santa Barbara
Hans Richard Barthel, M.d, M.D
Rheumatology — Payments: $32,207
Christian Powell
Rheumatology — Payments: $21,653
Sara Taroumian, M.d, M.D
Rheumatology — Payments: $17,319
Susan Lemon, Do, DO
Rheumatology — Payments: $14,104
Dr. Timothy Spiegel, M.d, M.D
Rheumatology — Payments: $12,362
Guy Clark, Md, MD
Rheumatology — Payments: $3,579